Technological evolution and reduction in diagnostic turnaround time of extrapulmonary tuberculosis: a 20-year analysis in a reference laboratory.
文献摘要
Extrapulmonary tuberculosis (EPTB) represents a diagnostic challenge due to its predominantly paucibacillary nature, contributing to delays in detection and negatively impacting clinical management and disease control. In recent decades, technologies such as molecular rapid tests (GeneXpert® MTB/RIF and MTB/RIF Ultra) and automated liquid culture systems (MGIT™) have substantially transformed the diagnostic landscape. This study evaluated the impact of these technologies on diagnostic turnaround time and accuracy in EPTB over a 20-year period in a university reference laboratory in northwestern Paraná, Brazil. A total of 1,305 extrapulmonary samples collected between 2005 and 2025 were analyzed and stratified into four technological phases according to diagnostic implementation. High diagnostic performance was observed, with an accuracy of 99.6% for automated culture and 97.4% for molecular testing. Quantile regression demonstrated a progressive reduction in turnaround time across phases, with the greatest decrease in the most recent phase. The mean turnaround time for positive samples decreased from 67 days to 34 days. Overall, the implementation of automated and molecular technologies maintained high diagnostic accuracy while reducing turnaround times, highlighting the importance of continuous technological advancement for timely EPTB diagnosis.